| 0 | ℹ |
Diverse routes to Cas3 activation in type I CRISPR-Cas immunity.
(linkinghub.elsevier.com)
|
Cell Reports 2026-09-10 | #crispr #immunity #nuclease #mechanism | |
| 0 | ℹ |
Genome-wide CRISPR screens map synthetic lethal interactions across recurrent cancer driver alterations.
(linkinghub.elsevier.com)
|
Cell Reports 2026-09-10 | #cancer #crispr #synthetic lethality #screening #driver mutations |